|
Our Company
The sensor technology behind
Bloodhound™ was invented in
the Biochemistry & Molecular
Biology Department
at the University of Leeds
and developed by a
‘spin-out’ company,
Bloodhound Sensors Limited,
formed in 1995 to exploit
the research. The company
carried out extensive
development work with
funding from feasibility and
research contracts to
produce the first Bloodhound™
BH114 instrument in 1997.
Since then Bloodhound™
products have been sold for
use in many
technical fields. Technical papers have been
published by research teams
using the Bloodhound™
BH114 and these demonstrate
its potential in a wide
range of application areas.
Today, the development of
Scensive is led by the
biotechnologist and leading
expert in the electronic
nose field, Dr Tim Gibson.
He and electronics engineer Rob Chandler were key
members of the original Leeds based
team which developed the
Bloodhound™
instrument. Together
they bring a wealth of
knowledge and technical experience to
the business.
The business is backed by
venture capital from the
Yorkshire based Viking Fund
and a group of private and
trade investors. In 2005 Scensive acquired the
assets of Bloodhound Sensors
Limited from the University
of Leeds and began
manufacturing its own
Bloodhound™ products based
on upgraded BH114
technology.
The applications for this
technology are almost
unlimited and Scensive is establishing
strategic partnerships with
organisations who recognise
the potential for this
technology and wish to
develop application specific
products.
|